Cationic Hyperbranched Starch Gene Carrier
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current gene carriers, such as nanoliposomes and polyamide-amine (PAMAM) dendrimers, face challenges in safety and efficacy due to potential allergenicity and structural changes, while natural starch lacks hydrophobicity and resistance as a gene carrier, necessitating modification that often damages its branching structure.
Innovation Solution
A method for preparing a cationic hyperbranched starch-based gene carrier through enzymatic hydrolysis and etherification reactions to increase branching and reduce molecular weight, creating a carrier with a low degree of substitution and high surface area for effective siRNA delivery, using starch branching enzymes and cationic etherifying agents to form a stable complex with gene fragments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If natural starch is used as a gene carrier, then safety is improved, but gene delivery efficacy deteriorates due to poor hydrophobicity and low resistance
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of starch through etherification reactions, introducing cationic groups to change the charge parameter and hydrophobicity. This transformation converts natural starch into a cationic hyperbranched starch-based gene carrier, improving gene delivery efficacy while maintaining the safety advantages of natural starch.
Solution Approach 2:
The patent creates a composite material by combining starch with cationic groups through etherification, forming a hybrid structure that integrates the safety benefits of natural starch with the gene delivery capabilities of cationic polymers. The resulting cationic hyperbranched starch-based gene carrier exhibits both safety and high gene delivery efficacy.
2Length of moving object
If starch is modified by enzymatic hydrolysis or acid hydrolysis to improve gene carrier performance, then molecular weight is reduced, but the natural branching structure is damaged and molecular weight distribution becomes uneven
Solution Approach 1:
The patent uses transglycosylation as an intermediary process that enables controlled modification of starch without directly damaging its branching structure. By using enzymatic transglycosylation followed by etherification, the method achieves molecular weight reduction and cationic group introduction while preserving the essential hyperbranched architecture of natural starch.
Solution Approach 2:
The patent applies preliminary action by first performing transglycosylation to prepare the starch structure for subsequent etherification. This sequential approach allows controlled modification before the final cationic group introduction, preventing structural damage that would occur with direct harsh hydrolysis methods.
3Reliability
If polyamide-amine (PAMAM) dendrimers are used as gene carriers, then gene loading and protective effects are improved, but safety deteriorates due to potential allergenicity and structural changes during PEGylation
Solution Approach 1:
The patent replaces expensive and potentially allergenic synthetic PAMAM dendrimers with a biocompatible natural starch-based carrier. The cationic hyperbranched starch-based gene carrier provides comparable gene loading and protective effects while eliminating the allergenicity associated with PEGylation of synthetic polymers, offering a safer alternative.
Solution Approach 2:
The patent changes the fundamental chemical parameters of the gene carrier by using natural starch as the base material instead of synthetic polymers. Through controlled etherification, the starch acquires cationic characteristics necessary for gene complexation, achieving the required gene loading capacity without the safety issues of synthetic dendrimers.
4Reliability
If the degree of substitution of starch-based gene carrier is increased to improve encapsulation effect, then gene encapsulation is improved, but structural complexity and potential toxicity increase
Solution Approach 1:
The patent applies partial action by introducing cationic groups through etherification at a controlled, moderate level rather than complete substitution. This partial modification is sufficient to achieve effective gene encapsulation and complexation while avoiding the excessive structural complexity and potential toxicity that would result from high degrees of substitution.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cationic hyperbranched starch-based gene carrier achieves complete encapsulation and protection of siRNA, with a nanoscale particle size and high loading capacity, offering a safe and effective non-toxic delivery system with controlled structure and reaction, expanding the utilization of starch resources.
Implementation Method 1
increasing the degree of branching of a starch molecule, reducing the molecular weight of the starch molecule, and providing certain resistance for a system through transglycosylation and hydrolysis of starch branching enzymes
Implementation Method 2
transglycosylation and hydrolysis of starch branching enzymes
Implementation Method 3
The positively charged starch derivative can interact with a gene fragment electrostatically to form a stable complex
Implementation Method 4
a high specific surface area of the highly branched structure increases the loading capacity of siRNA through adsorption
Data Source
AI summary
The disclosure discloses a method for preparing a nanoscale cationic hyperbranched starch-based gene carrier, which mainly includes the following steps: heating and gelatinizing a dextrin solution, then obtaining a highly branched cluster dextrin molecule having abundant short chains through hydrolysis and transglycosylation of starch branching enzymes, and then performing an etherification reaction to obtain cationic polymers with different degrees of substitution. The polymer is controllable in degradation, the highly branched structure thereof can reduce the requirement of the gene carrier on the high degree of substitution of cationic starch to a certain extent, and the cytotoxicity is obviously reduced. In addition, the polymer carrier can form a stable nanocomplex with a gene fragment, and has wide application in gene therapy as an efficient gene carrier.